Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Chun-hui Lu"'
Publikováno v:
Journal of Epidemiology and Global Health, Vol 14, Iss 1, Pp 213-222 (2024)
Abstract Background Chronic obstructive pulmonary disease (COPD) is a preventable and treatable chronic condition characterized by progressive, partially reversible airflow obstruction. Osteoporosis represents a significant comorbidity in individuals
Externí odkaz:
https://doaj.org/article/8d0f8b18286d41ce931d861a58409e46
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/82687dc8ab654bc5878cea235e7cb6de
Publikováno v:
Journal of Epidemiology and Global Health, Vol 14, Iss 3, Pp 1366-1366 (2024)
Externí odkaz:
https://doaj.org/article/68d0e8e114474632a950ad56b6f4786f
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Surgical patients with aortic dissection often require multiple antihypertensive drugs to control blood pressure. However, the prescription pattern and effectiveness of antihypertensive drugs for these patients are unclear. We aimed to in
Externí odkaz:
https://doaj.org/article/e365d00964944a4f9b993783b8d30b8b
Publikováno v:
Frontiers in Pharmacology; 2024, p1-14, 14p
Autor:
Chun-Hui Lu, Chih-Wun Fang, Hao-Ming Chen, Yi-Ping Fang, Chein-Tang Fang, Yaw-Bin Huang, Chung-Yu Chen, Kuang-Ming Liao, Shu-Chuan Jennifer Yeh
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Coronary artery aneurysm (CAA) is a rare disease, and there are limited data on prescribing patterns for CAA. The aim of our study was to investigate prescribing patterns for CAA in Taiwan via the National Health Insurance Researc
Externí odkaz:
https://doaj.org/article/25a0f4269a9c4d058f0e0a10c5eab67c
Publikováno v:
Frontiers in Pharmacology; 2023, p1-14, 14p
Autor:
Jing Gung Chung, Hsiao Chia Wang, Chun Min Su, Chun Hui Lu, Chien Kai Lai, Fei-Ting Hsu, Yu Cheng Kuo
Publikováno v:
In Vivo. 34:631-638
Background/aim Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and the third leading cause of cancer death worldwide. Although multiple chemotherapies options are available for HCC, chemo-induced toxicity is inevitable during clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::093a870563140f68bc28606e3dd5d75f
https://doi.org/10.21873/invivo.11817
https://doi.org/10.21873/invivo.11817
Autor:
CHUN-MIN SU, HSIAO-CHIA WANG, FEI-TING HSU, CHUN-HUI LU, CHIEN-KAI LAI, JING-GUNG CHUNG, YU-CHENG KUO
Publikováno v:
In Vivo; Mar/Apr2020, Vol. 34 Issue 2, p631-638, 8p
Autor:
Chun-Min, Su, Hsiao-Chia, Wang, Fei-Ting, Hsu, Chun-Hui, Lu, Chien-Kai, Lai, Jing-Gung, Chung, Yu-Cheng, Kuo
Publikováno v:
In vivo (Athens, Greece). 34(2)
Background/Aim: Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and the third leading cause of cancer death worldwide. Although multiple chemotherapies options are available for HCC, chemo-induced toxicity is inevitable during cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2efa8908b4fdb7ca420b7f821b59760d
https://pubmed.ncbi.nlm.nih.gov/32111763
https://pubmed.ncbi.nlm.nih.gov/32111763